{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T04:13:54Z","timestamp":1649132034610},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s11239-008-0234-x","type":"journal-article","created":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T14:52:07Z","timestamp":1212159127000},"page":"421-429","source":"Crossref","is-referenced-by-count":1,"title":["Indications of combined vitamin K antagonists and aspirin therapy"],"prefix":"10.1007","volume":"27","author":[{"given":"A.","family":"Loualidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. H. J.","family":"Bredie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C. H.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,31]]},"reference":[{"issue":"7329","key":"234_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. Br Med J 324(7329):71\u201386","journal-title":"Br Med J"},{"issue":"21","key":"234_CR2","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/jama.282.21.2058","volume":"282","author":"SS Anand","year":"1999","unstructured":"Anand SS, Yusuf S (1999) Oral anticoagulants in patients with coronary artery disease: a meta analysis. JAMA 282(21):2058\u20132067","journal-title":"JAMA"},{"issue":"10","key":"234_CR3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.4065\/79.10.1330","volume":"79","author":"KD Flemming","year":"2004","unstructured":"Flemming KD, Brown RD Jr (2004) Secondary prevention strategies in ischemic stroke: identification and optimal management of modifiable risk factors. Mayo Clin Proc 79(10):1330\u20131340","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"234_CR4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"RG Hart","year":"1999","unstructured":"Hart RG, Benavaente O, McBride R et\u00a0al (1999) Antithrombotic therapy to prevent stroke in AF: a meta-analysis. Ann Intern Med 131(7):492\u2013501","journal-title":"Ann Intern Med"},{"issue":"3 suppl","key":"234_CR5","doi-asserted-by":"crossref","first-page":"429S","DOI":"10.1378\/chest.126.3_suppl.429S","volume":"126","author":"DE Singer","year":"2004","unstructured":"Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ (2004) Antithrombotic therapy in atrial fibrillation: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 suppl):429S\u2013456S","journal-title":"Chest"},{"issue":"9028","key":"234_CR6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","volume":"348","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1996","unstructured":"Stroke Prevention in Atrial Fibrillation Investigators (1996) Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised clinical trial. Lancet 348(9028):633\u2013638","journal-title":"Lancet"},{"issue":"12","key":"234_CR7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archinte.159.12.1322","volume":"159","author":"AL Gullov","year":"1999","unstructured":"Gullov AL, Koefoed BG, Peterson P (1999) Bleeding during warfarin and aspirin therapy, in patients with atrial fibrillation, The AFASAK 2 study. Arch Intern Med 159(12):1322\u20131328","journal-title":"Arch Intern Med"},{"issue":"3","key":"234_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000047711","volume":"12","author":"P Lechat","year":"2001","unstructured":"Lechat P, Lardoux H, Mallet A, Sanchez P, Derumeaux G, Lecompte T et\u00a0al (2001) Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation a randomised trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontan\u00e9; FFAACS). Cerebrovasc Dis 12(3):245\u2013252","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"234_CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2796.2003.01159.x","volume":"254","author":"N Edvardsson","year":"2003","unstructured":"Edvardsson N, Juul-Moller SJ et\u00a0al (2003) Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation. J Intern Med 254(1):95\u2013101","journal-title":"J Intern Med"},{"issue":"8","key":"234_CR10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archinte.166.8.853","volume":"166","author":"JD Douketis","year":"2006","unstructured":"Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halperin F, Horrow J (2006) Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin. Arch Intern Med 166(8):853\u2013859","journal-title":"Arch Intern Med"},{"key":"234_CR11","unstructured":"Michel PL, Acar J (1998) Proth\u00e8ses valvulaires m\u00e9caniques et biologiques et traitements antithrombotiques. In: Samama MM, Acar J (eds) Traitement Antithrombotique, Masson Edit, 3rd edn. Paris, pp 143\u2013175"},{"issue":"3","key":"234_CR12","first-page":"172","volume":"9","author":"J Acar","year":"1997","unstructured":"Acar J, Michel PL, Iung B (1997) Les accidents thromboemboliques des proth\u00e8ses valvulaires: incidence, pr\u00e9vention et traitement en 1997. Sang Thromb Vaiss 9(3):172\u2013178","journal-title":"Sang Thromb Vaiss"},{"issue":"4","key":"234_CR13","first-page":"457","volume":"9","author":"M Aupart","year":"1997","unstructured":"Aupart M, Diemont F, Babuty S et\u00a0al (1997) R\u00e9sultats interm\u00e9diaires avec la proth\u00e8se valvulaire \u00e0 ailettes CarboMedics. Arch Mal Coeur 9(4):457\u2013462","journal-title":"Arch Mal Coeur"},{"issue":"2","key":"234_CR14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","volume":"89","author":"SC Cannegieter","year":"1994","unstructured":"Cannegieter SC, Rosendaal FR, Briet E (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89(2):635\u2013641","journal-title":"Circulation"},{"key":"234_CR15","unstructured":"Little SH, Massel DR (2003) Antiplatelet and anticoagulation for patients with prosthetic heart valves. The Cochrane Database of Systematic Reviews Issue (4):CD003464"},{"issue":"3 suppl","key":"234_CR16","doi-asserted-by":"crossref","first-page":"457S","DOI":"10.1378\/chest.126.3_suppl.457S","volume":"126","author":"DN Salem","year":"2004","unstructured":"Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, Pauker SG (2004) Antithrombotic therapy in valvular heart disease\u2014native and prosthetic: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 suppl):457S\u2013482S","journal-title":"Chest"},{"issue":"2","key":"234_CR17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archinte.167.2.117","volume":"167","author":"F Dentali","year":"2007","unstructured":"Dentali F, Douketis JD, Lim W, Crowther M (2007) Combined aspirin\u2013oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med 167(2):117\u2013124","journal-title":"Arch Intern Med"},{"issue":"2","key":"234_CR18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(00)01135-9","volume":"37","author":"D Massel","year":"2001","unstructured":"Massel D, Little SH (2001) Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. J Am Coll Cardiol 37(2):569\u2013578","journal-title":"J Am Coll Cardiol"},{"key":"234_CR19","doi-asserted-by":"crossref","unstructured":"Dale J, Myhre E, Loew D (1980) Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement. Am Heart J 99:746\u2013752","DOI":"10.1016\/0002-8703(80)90625-0"},{"key":"234_CR20","doi-asserted-by":"crossref","unstructured":"Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV (1983) Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 51(9):1537\u20131541","DOI":"10.1016\/0002-9149(83)90673-2"},{"key":"234_CR21","doi-asserted-by":"crossref","unstructured":"Turpie AG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, Klimek M, Hirsh J (1993) A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 329(8):524\u2013529","DOI":"10.1056\/NEJM199308193290802"},{"key":"234_CR22","doi-asserted-by":"crossref","unstructured":"Altman R, Rouvier J, Gurfinkel E et al (1996) Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant. Circulation 94:2113\u20132116","DOI":"10.1161\/01.CIR.94.9.2113"},{"key":"234_CR23","doi-asserted-by":"crossref","unstructured":"Meschengieser SS, Fondevilla C, Santarelli MT et al (1997) Low intensity oral anticoagulation plus low dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg 113:910\u2013916","DOI":"10.1016\/S0022-5223(97)70264-2"},{"key":"234_CR24","doi-asserted-by":"crossref","unstructured":"Laffort P, Roudaut R, Roques X, Lafitte S, Deville C, Bonnet J, Baudet E (2000) Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study. J Am Coll Cardiol 35:739\u2013746","DOI":"10.1016\/S0735-1097(99)00598-7"},{"key":"234_CR25","doi-asserted-by":"crossref","unstructured":"Casais P, Meschengieser SS, Sanchez Luceros AG, Bermejo EI, Lazzari MA (2002) Effect of low-dose aspirin on the international normalized ratio variability in patients with mechanical heart valve prostheses. Pathophysiol Haemost Thromb 32:155\u2013157","DOI":"10.1159\/000070420"},{"issue":"6921","key":"234_CR26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1994","unstructured":"Antiplatelet Trialists\u2019 Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308(6921):81\u2013106","journal-title":"Br Med J"},{"issue":"2","key":"234_CR27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.60.2.197","volume":"60","author":"A Algra","year":"1996","unstructured":"Algra A, van Gijn J (1996) Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry 60(2):197\u2013199","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"234_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jnnp.66.2.255","volume":"66","author":"A Algra","year":"1999","unstructured":"Algra A, van Gijn J (1999) Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin. J Neurol Neurosurg Psychiatry 66(2):255; Letter","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"234_CR29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.STR.0000047035.04395.ED","volume":"34","author":"A Algra","year":"2003","unstructured":"Algra A, De Schryver ELLM, van Gijn J, Kappelle LJ, Koudstaal PJ (2003) Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed arterial origin. Stroke 34(1):234\u2013235","journal-title":"Stroke"},{"issue":"1","key":"234_CR30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000092331","volume":"22","author":"WARSS Investigators","year":"2006","unstructured":"WARSS Investigators (2006) Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study. Cerebrovasc Dis 22(1):4\u201312","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"234_CR31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJM199003153221107","volume":"322","author":"AJ Moss","year":"1990","unstructured":"Moss AJ, Benhorin J (1990) Prognosis and management after a first myocardial infarction. N Engl J Med 322(11):743\u2013753","journal-title":"N Engl J Med"},{"issue":"12","key":"234_CR32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0002-9149(93)91100-V","volume":"72","author":"R Kornowski","year":"1993","unstructured":"Kornowski R, Goldbourt U, Zion M, Mandelzweig L, Kaplinsky E, Levo Y et\u00a0al (1993) Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group. Am J Cardiol 72(12):883\u2013888","journal-title":"Am J Cardiol"},{"issue":"1","key":"234_CR33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.90.1.61","volume":"90","author":"PA Merlini","year":"1994","unstructured":"Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD (1994) Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 90(1):61\u201368","journal-title":"Circulation"},{"key":"234_CR34","doi-asserted-by":"crossref","unstructured":"Cohen M, Adams PC, Parry G, Xiong J, Chamberlain D, Wieczorek I, Fox KA, Chesebro JH, Strain J, Keller C et al (1994) Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation 89(1):81\u201388","DOI":"10.1161\/01.CIR.89.1.81"},{"key":"234_CR35","doi-asserted-by":"crossref","unstructured":"CARS Investigators (1997) Randomized double blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet 350:389\u2013396","DOI":"10.1016\/S0140-6736(97)01180-X"},{"issue":"9201","key":"234_CR36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","volume":"355","author":"Anonymous","year":"2000","unstructured":"Anonymous (2000) Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 355(9201):346\u2013351","journal-title":"Lancet"},{"key":"234_CR37","doi-asserted-by":"crossref","unstructured":"The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators (2001) Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina. J Am Coll Cardiol 37:475\u2013484","DOI":"10.1016\/S0735-1097(00)01118-9"},{"key":"234_CR38","doi-asserted-by":"crossref","unstructured":"Huynh T, Th\u00e9roux P, Bogaty P, Nasmith J, Solymoss S (2001) Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery. Circulation 103(25):3069\u20133074","DOI":"10.1161\/01.CIR.103.25.3069"},{"key":"234_CR39","doi-asserted-by":"crossref","unstructured":"Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H (2002) Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347:969\u2013974","DOI":"10.1056\/NEJMoa020496"},{"key":"234_CR40","doi-asserted-by":"crossref","unstructured":"van Es RF, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE (2002) Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 (ASPECT-2) Research Group. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet 360(9327):109\u2013113","DOI":"10.1016\/S0140-6736(02)09409-6"},{"key":"234_CR41","doi-asserted-by":"crossref","unstructured":"Fiore LD, Ezekowitz MD, Brophy MT et al (2002) Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study. Circulation 105:557\u2013563","DOI":"10.1161\/hc0502.103329"},{"key":"234_CR42","doi-asserted-by":"crossref","unstructured":"Herlitza J, Holmb J, Petersonc M, Karlsona BW, Evandera MH, Erhardtb L, for the LoWASA study group (2004) Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction the LoWASA study. Eur Heart J 25:232\u2013239","DOI":"10.1016\/j.ehj.2003.10.026"},{"issue":"4 suppl","key":"234_CR43","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1016\/S0735-1097(02)02776-6","volume":"41","author":"S Anand","year":"2003","unstructured":"Anand S, Yusuf S (2003) Oral anticoagulants in patients with coronary artery disease. J Am Coll Cardiol 41(4 suppl):62S\u201369S","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"234_CR44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-143-4-200508160-00005","volume":"143","author":"MB Rothberg","year":"2005","unstructured":"Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR (2005) Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Ann Intern Med 143(4):241\u2013250","journal-title":"Ann Intern Med"},{"issue":"8812","key":"234_CR45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0140-6736(92)93216-A","volume":"340","author":"SZ Goldhaber","year":"1992","unstructured":"Goldhaber SZ, Manson JE, Stampfer MJ, LaMotte F, Rosner B, Buring JE, Hennekens CH (1992) Low-dose aspirin and subsequent peripheral arterial surgery in the Physician\u2019s Health Study. Lancet 340(8812):143\u2013145","journal-title":"Lancet"},{"issue":"4 suppl","key":"234_CR46","first-page":"327S","volume":"102","author":"J Hirsh","year":"1992","unstructured":"Hirsh J, Dalen JE, Fuster V, Harker LB, Salzman EW (1992) Aspirin and other anti-platelet drugs: the relationship between dose, effectiveness, and side effects. Chest 102 (4 suppl):327S\u2013336S","journal-title":"Chest"},{"issue":"8899","key":"234_CR47","first-page":"687","volume":"343","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1994","unstructured":"Stroke Prevention in Atrial Fibrillation Investigators (1994) Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in Atrial Fibrillation II study. Lancet 343(8899):687\u2013691","journal-title":"Lancet"},{"issue":"9","key":"234_CR48","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archsurg.1992.01420090120018","volume":"127","author":"G Kretschmer","year":"1992","unstructured":"Kretschmer G, Herbst F, Prager M, Sautner T, Wenzl E, Berlakovich GA, Zekert F, Marosi L, Schemper M (1992) A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis. Arch Surg 127(9):1112\u20131115","journal-title":"Arch Surg"},{"issue":"6","key":"234_CR49","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0002-9610(06)80065-6","volume":"159","author":"B Arfvidsson","year":"1990","unstructured":"Arfvidsson B, Lundgren F, Drott C et\u00a0al (1990) Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery. Am J Surg 159(6):556\u2013560","journal-title":"Am J Surg"},{"issue":"1","key":"234_CR50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF02601991","volume":"24","author":"P Smit de","year":"1992","unstructured":"de Smit P, van Urk H (1992) Dutch oral anticoagulation trial. Act Chir Austr 24(1):5\u20137","journal-title":"Act Chir Austr"},{"issue":"3","key":"234_CR51","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0741-5214(98)70130-2","volume":"28","author":"TP Sarac","year":"1998","unstructured":"Sarac TP, Huber TS, Back MR et\u00a0al (1998) Warfarin improves the outcome of infrainguinal vein bypass grafting at high-risk for failure. J Vasc Surg 28(3):446\u2013457","journal-title":"J Vasc Surg"},{"issue":"3","key":"234_CR52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mva.2002.121847","volume":"35","author":"WC Johnson","year":"2002","unstructured":"Johnson WC, Williford WO (2002) Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomised study. J Vasc Surg 35(3):413\u2013421","journal-title":"J Vasc Surg"},{"issue":"4","key":"234_CR53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1067\/mhj.2000.109648","volume":"140","author":"CM Chesney","year":"2000","unstructured":"Chesney CM, Elam MB, Herd JA, Davis KB, Garg R, Hunninghake, Kennedy JW, Applegate WB (2000) Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the arterial disease multiple intervention trial (ADMIT). Am Heart J 140(4):631\u2013636","journal-title":"Am Heart J"},{"issue":"3","key":"234_CR54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","volume":"357","author":"The Warfarin Antiplatelet Vascular Evaluation Trial Investigators","year":"2007","unstructured":"The Warfarin Antiplatelet Vascular Evaluation Trial Investigators (2007) Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 357(3):217\u2013227","journal-title":"N Engl J Med"},{"issue":"2","key":"234_CR55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"RL Sacco","year":"2006","unstructured":"Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K et\u00a0al (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 37(2):577\u2013617","journal-title":"Stroke"},{"issue":"3 suppl","key":"234_CR56","doi-asserted-by":"crossref","first-page":"483S","DOI":"10.1378\/chest.126.3_suppl.483S","volume":"126","author":"GW Albers","year":"2004","unstructured":"Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P (2004) Antithrombotic and thrombolytic therapy for ischemic stroke: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 suppl):483S\u2013512S","journal-title":"Chest"},{"issue":"1 Suppl","key":"234_CR57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1538-7836.2007.02499.x","volume":"5","author":"JW Eikelboom","year":"2007","unstructured":"Eikelboom JW, Hirsh L (2007) Combined antiplatelet and anticoagulant therapy: clinical benefits and risks. J Thromb Haemost 5(1 Suppl):255\u2013263","journal-title":"J Thromb Haemost"},{"issue":"4","key":"234_CR58","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/153857448501900405","volume":"19","author":"DR Donaldson","year":"1985","unstructured":"Donaldson DR, Salter MC, Kester RC et\u00a0al (1985) The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts. J Vasc Surg 19(4)224\u2013230","journal-title":"J Vasc Surg"},{"issue":"4","key":"234_CR59","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/153857448401800404","volume":"18","author":"MD Goldman","year":"1984","unstructured":"Goldman MD, McCollum CN (1984) A prospective randomised study to examine the effect of aspirin plus dipyridamole on the patency of prosthetic femoro-popliteal grafts. J Vasc Surg 18(4):217\u2013221","journal-title":"J Vasc Surg"},{"issue":"6","key":"234_CR60","first-page":"1016","volume":"92","author":"RM Green","year":"1982","unstructured":"Green RM, Roedersheimer LR, DeWeese JA (1982) Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. Surgery 92(6):1016\u20131026","journal-title":"Surgery"},{"issue":"3","key":"234_CR61","first-page":"462","volume":"96","author":"TR Kohler","year":"1984","unstructured":"Kohler TR, Kaufman JL, Kacoyanis GP et\u00a0al (1984) Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery 96(3):462\u2013466","journal-title":"Surgery"},{"issue":"1","key":"234_CR62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0741-5214(91)90022-M","volume":"13","author":"C McCollum","year":"1991","unstructured":"McCollum C, Alexander C, Kenchington G, Franks PJ, Greenhalgh RM (1991) Anti-platelet drugs in femoropopliteal vein bypasses: a multicentre trial. J Vasc Surg 13(1):150\u2013162","journal-title":"J Vasc Surg"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-008-0234-x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T15:23:48Z","timestamp":1555601028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-008-0234-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,31]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1007\/s11239-008-0234-x","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,31]]}}}